Moleculin Stock Rises After FDA Grants Annamycin Orphan Drug Designation For Soft Tissue Sarcomas

·

·

Moleculin Stock Rises After FDA Grants Annamycin Orphan Drug Designation For Soft Tissue Sarcomas

(RTTNews) – Moleculin Biotech, Inc., (MBRX), a clinical stage pharmaceutical company, said Tuesday that the U.S. Food and Drug Administration or FDA has granted Orphan Drug Designation (ODD) to Annamycin for treatment of soft tissue sarcomas.
See Original Article

North Versailles tobacco shop sells winning $100000 lottery ticket

7 minutes ago. A customer at a North Versailles tobacco store is $100,000 richer this holiday season after their New Year’s Millionaire Raffle ticket was selected for a weekly drawing prize. The winner, who was not identified, purchased the ticket at Puff …
See Original Article

Global Smartphone Power Management IC Industry

New York, Dec. 29, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Smartphone Power Management IC Industry” – https://www.reportlinker.com/p05960113/?utm_source=GNW 1 Billion by 2027, growing at a CAGR …
See Original Article

US Inequality, Global 2021 Outlook, EU-China Deal: Eco Day

Photographs: Bloomberg. Welcome to Tuesday, Americas. Here's the latest news and analysis from Bloomberg Economics to help you start the day:.
See Original Article

Camping World CEO donates $500000 to businesses affected by Nashville bombing

NASHVILLE, Tenn. (WZTV) — Downtown Nashville businesses left in rubble after a Christmas Day bomb are getting some much-needed help from a businessman and TV personality. Marcus Lemonis, Camping World CEO and CNBC host, posted on Twitter …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.